First Horizon Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.55 Billion
- Q4 2024
A detailed history of First Horizon Advisors, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 504 shares of AGIO stock, worth $16,783. This represents 0.0% of its overall portfolio holdings.
Number of Shares
504
Previous 507
0.59%
Holding current value
$16,783
Previous $22,000
27.27%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding AGIO
# of Institutions
237Shares Held
57.1MCall Options Held
374KPut Options Held
394K-
Farallon Capital Management LLC San Francisco, CA5.66MShares$189 Million1.26% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.63MShares$188 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$162 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.74MShares$124 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.83MShares$94.3 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.83B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...